The case addressed a $100 million earnout payment under Medtronic Minimed’s acquisition of Companion Medical that would be triggered if Medtronic’s sales of two “smart insulin pens ...

Sumitomo Mitsui Trust Group Inc. lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 0.5% in the 3rd quarter, according to its most recent filing with the SEC.

Generic Drugs Drive Sales in TEVA’s United States Unit Sales in the United States segment (previously the North America segment) were $2.22 billion, up 17% year over year, driven by higher sales ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...

Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Teva Zaveroni hails the performances of rising star Heimanu Terorotua at the OFC Beach Soccer Nations Cup and backs Tahiti to shine at Seychelles 2025. Not many people know that Teva Zaveroni, the ...